These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24588292)

  • 1. Harm reduction behaviors among young polysubstance users at raves.
    Fernández-Calderón F; Lozano-Rojas Ó; Rojas-Tejada A; Bilbao-Acedos I; Vidal-Giné C; Vergara-Moragues E; González-Saiz F
    Subst Abus; 2014; 35(1):45-50. PubMed ID: 24588292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysubstance use patterns in underground rave attenders: a cluster analysis.
    Fernandez-Calderón F; Lozano OM; Vidal C; Ortega JG; Vergara E; González-Sáiz F; Bilbao I; Caluente M; Cano T; Cid F; Dominguez C; Izquierdo E; Pérez MI
    J Drug Educ; 2011; 41(2):183-202. PubMed ID: 21888000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of use, harm reduction strategies, and their relation to risk behavior and harm in recreational ketamine users.
    Vidal Giné C; Fernández Calderón F; López Guerrero J
    Am J Drug Alcohol Abuse; 2016 May; 42(3):358-69. PubMed ID: 27052358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction in the rave community.
    Henricksen K
    Focus; 2000 Mar; 15(4):1-4. PubMed ID: 11367305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysubstance use: diagnostic challenges, patterns of use and health.
    Connor JP; Gullo MJ; White A; Kelly AB
    Curr Opin Psychiatry; 2014 Jul; 27(4):269-75. PubMed ID: 24852056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs.
    Fernández-Calderón F; Díaz-Batanero C; Barratt MJ; Palamar JJ
    Drug Alcohol Rev; 2019 Jan; 38(1):57-67. PubMed ID: 30302851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Raves and drug use from an epidemiologic and psychosocial approach: a bibliographic systematic review].
    Fernández-Calderón F; Lozano-Rojas ÓM; Rojas-Tejada AJ
    Adicciones; 2013; 25(3):269-79. PubMed ID: 23880840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Party subculture or dens of doom? An epidemiological study of rave attendance and drug use patterns among adolescent students.
    Adlaf EM; Smart RG
    J Psychoactive Drugs; 1997; 29(2):193-8. PubMed ID: 9250946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illicit drug use among rave attendees in a nationally representative sample of US high school seniors.
    Palamar JJ; Griffin-Tomas M; Ompad DC
    Drug Alcohol Depend; 2015 Jul; 152():24-31. PubMed ID: 26005041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm Reduction Strategies and Drug-Related Negative Consequences in the Dance Music Scene: The Moderating Role of Polysubstance Use.
    Vera BDV; Carmona-Marquez J; Vidal-Giné C; Fernández-Calderón F
    Subst Use Misuse; 2021; 56(6):777-781. PubMed ID: 33663340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Party drugs - use and harm reduction.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and benefit perceptions of party drug use.
    White B; Degenhardt L; Breen C; Bruno R; Newman J; Proudfoot P
    Addict Behav; 2006 Jan; 31(1):137-42. PubMed ID: 15907371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing patterns of first injection across key periods of the French Harm Reduction Policy: PrimInject, a cross sectional analysis.
    Guichard A; Guignard R; Michels D; Beck F; Arwidson P; Lert F; Roy E
    Drug Alcohol Depend; 2013 Nov; 133(1):254-61. PubMed ID: 23726980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views.
    Chiauzzi E; Dasmahapatra P; Lobo K; Barratt MJ
    Subst Use Misuse; 2013 Jun; 48(8):661-70. PubMed ID: 23750771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.
    Bonny-Noach H; Shapira B; Baumol P; Tadmor N; Rosca P; Shoshan S; Harel-Fisch Y; Caduri A
    Harm Reduct J; 2023 Aug; 20(1):108. PubMed ID: 37559046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.